Acer Therapeutics Inc. Quarterly Debt-to-equity in % from Q3 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Acer Therapeutics Inc. quarterly Debt-to-equity history and growth rate from Q3 2012 to Q3 2023.
  • Acer Therapeutics Inc. Debt-to-equity for the quarter ending September 30, 2023 was -145 %, a 65.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 -145 +279 +65.8% Sep 30, 2023
Q2 2023 -165 +605 +78.6% Jun 30, 2023
Q1 2023 -203 +2.8K +93.2% Mar 31, 2023
Q4 2022 -271 -1.39K -124% Dec 31, 2022
Q3 2022 -424 -908 -188% Sep 30, 2022
Q2 2022 -770 -1.04K -384% Jun 30, 2022
Q1 2022 -3.01K -3.15K -2254% Mar 31, 2022
Q4 2021 1.12K +1.08K +2816% Dec 31, 2021
Q3 2021 484 +459 +1831% Sep 30, 2021
Q2 2021 271 +254 +1481% Jun 30, 2021
Q1 2021 140 +124 +785% Mar 31, 2021
Q4 2020 38.3 +25 +187% Dec 31, 2020
Q3 2020 25.1 +12.5 +99.6% Sep 30, 2020
Q2 2020 17.1 +7.21 +72.7% Jun 30, 2020
Q1 2020 15.8 +6.64 +72.7% Mar 31, 2020
Q4 2019 13.4 +3.48 +35.2% Dec 31, 2019
Q3 2019 12.6 +3.86 +44.4% Sep 30, 2019
Q2 2019 9.92 -3.7 -27.2% Jun 30, 2019
Q1 2019 9.13 -3.32 -26.7% Mar 31, 2019
Q4 2018 9.9 -3.46 -25.9% Dec 31, 2018
Q3 2018 8.7 -41.8 -82.8% Sep 30, 2018
Q2 2018 13.6 +256 Jun 30, 2018
Q1 2018 12.5 -336 -96.4% Mar 31, 2018
Q4 2017 13.4 -133 -90.9% Dec 31, 2017
Q3 2017 50.5 -55.6 -52.4% Sep 30, 2017
Q2 2017 -243 -327 -387% Jun 30, 2017
Q1 2017 348 +275 +377% Mar 31, 2017
Q4 2016 147 +48.4 +49.3% Dec 31, 2016
Q3 2016 106 +39.1 +58.4% Sep 30, 2016
Q2 2016 84.5 +18 +27.1% Jun 30, 2016
Q1 2016 73 +9.63 +15.2% Mar 31, 2016
Q4 2015 98.2 +56.9 +137% Dec 31, 2015
Q3 2015 67 +32.3 +93% Sep 30, 2015
Q2 2015 66.5 +33.4 +101% Jun 30, 2015
Q1 2015 63.4 +19.9 +45.7% Mar 31, 2015
Q4 2014 41.4 -19.4 -32% Dec 31, 2014
Q3 2014 34.7 -51.5 -59.8% Sep 30, 2014
Q2 2014 33.1 -148 -81.7% Jun 30, 2014
Q1 2014 43.5 -60.3 -58.1% Mar 31, 2014
Q4 2013 60.8 +1.46 +2.46% Dec 31, 2013
Q3 2013 86.2 +42.6 +97.4% Sep 30, 2013
Q2 2013 181 Jun 30, 2013
Q1 2013 104 Mar 31, 2013
Q4 2012 59.3 Dec 31, 2012
Q3 2012 43.7 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.